Sialic acid recognition of the pandemic influenza 2009 H1N1 virus: Binding mechanism between human receptor and influenza hemagglutinin

Protein and Peptide Letters

Volumn 18, Issue 5, 2011, Pages 530-539

  Fukuzawa, Kaori ^a   Omagari, Katsumi ^b   Nakajima, Katsuhisa ^b   Nobusawa, Eri ^c   Tanaka, Shigenori ^d  

^a MIZUHO INFORMATION AND RESEARCH INSTITUTE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d KOBE UNIVERSITY   (Japan)

Author keywords

Fragment molecular orbital (FMO) method; Influenza hemagglutinin (HA); Pandemic influenza 2009 H1N1 virus (2009 H1N1pdm); Quantum mechanical calculation; Sialic acid recognition; Sialo sugar chain

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; N ACETYLNEURAMINIC ACID; OLIGOSACCHARIDE; SIALOOLIGOSACCHARIDES; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; PROTEIN BINDING; VIRUS ATTACHMENT;

AMINO ACID SEQUENCE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; N-ACETYLNEURAMINIC ACID; OLIGOSACCHARIDES; PROTEIN BINDING; RECEPTORS, VIRUS; VIRUS ATTACHMENT;

SUIDAE;

EID: 79952828578     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986611794927893     Document Type: Article

References (70)

1. Neumann, G.; Noda, T.; Kawaoka, Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature, 2009, 459, 931-939.
2. Smith, G. J. D.; Vijaykrishna, D.; Bahl, J.; Lycett, S. J.; Worobey, M.; Pybus, O. G.; Ma, S. K.; Cheung, C. L.; Raghwani, J.; Bhatt, S.; Malik Peiris, J. S.; Guan, Y.; Rambaut, A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature, 2009, 459, 1122-1126.
3. Garten, R. J.; Davis, C. T.; Russell, C. A.; Shu, B.; Lindstrom, S.; Balish, A.; Sessions, W. M.; Xu, X.; Skepner, E.; Deyde, V.; Okomo-Adhiambo, M.; Gubareva, L.; Barnes, J.; Smith, C. B.; Emery, S. L.; Hillman, M. J.; Rivailler, P.; Smagala, J.; de Graaf, M.; Burke, D. F.; Fouchier, R. A. M.; Pappas, C.; Alpuche-Aranda, C. M.; López-Gatell, H.; Olivera, H.; López, I.; Myers, C. A.; Faix, D.; Blair, P. J.; Yu, C.; Keene, K. M.; Dotson Jr., P. D.; Boxrud, D.; Sambol, A. R.; Abid, S. H.; St. George, K.; Bannerman, T.; Moore, A. L.; Stringer, D. J.; Blevins, P.; Demmler-Harrison, G. J.; Ginsberg, M.; Kriner, P.; Waterman, S.; Smole, S.; Guevara, H. F.; Belongia, E. A.; Clark, P. A.; Beatrice, S. T.; Donis, R.; Katz, J.; Finelli, L.; Bridges, C. B.; Shaw, M.; Jernigan, D. B.; Uyeki, T. M.; Smith, D. J.; Klimov, A. I.; Cox, N. J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 2009, 325, 197-201.
4. Schnitzler, S. U.; Schnitzler, P. An update on swine-origin influenza virus A/H1N1: a review. Virus Genes, 2009, 39, 279-292.
5. Soundararajan, V.; Tharakaraman, K.; Raman, R.; Raguram, S.; Shriver, Z.; Sasisekharan, V.; Sasisekharan, R. Extrapolating from sequence-the 2009 H1N1 'swine' influenza virus. Nat. Biotech., 2009, 27, 510-513.
6. Ito, T.; Couceiro, J. N. S. S.; Kelm, S; Baum, L. G.; Krauss, S.; Castrucci, M. R.; Donatelli, I.; Kida, H.; Paulson, J. C.; Webster, R. G.; Kawaoka Y. Molecular basis for the generation in pigs of influenza a viruses with pandemic potential. J. Virol., 1998, 72, 73677373.
7. Skehel, J. J.; Wiley, D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Ann. Rev. Biochem., 2000, 69, 531-569.
8. Horimoto, T.; Kawaoka, Y. Influenza: lessons from past pandemics, warnings from current incidents, Nat. Rev. Microbiol., 2005, 3, 591-600. (Pubitemid 41052146)
9. Neumann, G.; Kawaoka, Y. Host range restriction and pathogenicity in the context of influenza pandemic. Emerg. Infect. Dis., 2006, 12, 881-886. (Pubitemid 43848407)
10. Pielak, R. M.; Chou, J. J. Influenza M2 proton channels. Biochim. Biophys. Acta, 2010, 10.1016/j.bbamem.2010.1004.1015.
11. Suzuki, Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull., 2005, 28, 399-408. (Pubitemid 40879958)
12. Du, Q. S.; Wang, S. Q.; Huang, R. B.; Chou, K. C. Computational 3D structures of drug-targeting proteins in the 2009-H1N1influenza A virus. Chem. Phys. Lett., 2010, 485, 191-195.
13. Wang, J. F.; Chou, K. C. Insights from studying the mutationinduced allostery in the M2 proton channel by molecular dynamics. Protein Eng Des Sel., 2010, 23, 663-666.
14. Wang, J. F.; Wei, D. Q.; Chou, K. C. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus. Biochem. Biophys. Res. Commun., 2009, 388, 413-417.
15. Wang, S. Q.; Du, Q. S.; Huang, R. B.; Zhang, D. W.; Chou, K. C. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Biochem. Biophys. Res. Commun. 2009, 386, 432-436.
16. NCBI. Influenza Virus Resource. http://www.ncbi.nlm.nih.gov/genomes/FLU/ FLU.html
17. Xu, R.; Ekiert, D. C.; Krause, J. C.; Hai, R.; Crowe Jr., J. E.; Wilson I. A. Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus. Science, 2010, 328, 357-360.
18. Gamblin, S. J.; Haire, L. F.; Russell, R. J.; Stevens, D. J.; Xiao, B.; Ha, Y.; Vasisht, N.; Steinhauer, D. A.; Daniels, R. S.; Elliot, A.; Wiley, D. C.; Skehel J. J. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science, 2004, 303, 1838-1842. (Pubitemid 38374870)
19. Schnell, J. R.; Chou, J. J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature, 2008, 451, 591-595. (Pubitemid 351186272)
20. Pielak, R. M.; Jason R. Schnell, J. R.; Chou, J. J. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc. Natl. Acad. Sci. USA, 2009, 106, 7379-7384.
21. Wang, J.; Pielak, R. M.; McClintock, M. A.; Chou, J. J. Solution structure and functional analysis of the influenza B proton channel. Nat. Struct. Mol. Biol., 2009, 16, 1267-1271.
22. Pielak, R. M.; Chou, J. J. Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel. Biochem. Biophys. Res. Commun., 2010, 401, 58-63.
23. Pielak, R. M.; Chou, J. J. Flu channel drug resistance: a tale of two sites. Protein Cell, 2010, 1, 246-258.
24. Huang, R. B.; Du, Q. S.; Wang, C. H.; Chou, K. C. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus. Biochem. Biophys. Res. Comm., 2008, 377, 1243-1247.
25. Du, Q. S.; Huang, R. B.; Wang, C. H.; Li, X. M.; Chou, K. C. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J. Theor. Biol., 2009, 259, 159-164.
26. Wei, H.; Wang, C. H.; Du, Q. S.; Meng, J.; Chou, K. C. Investigation into adamantane-based M2 inhibitors with FB-QSAR. Med. Chem., 2009, 5, 305-317.
27. Wang, N. X.; Zheng, J. J. Computational studies of H5N1 influenza virus resistance to oseltamivir. Protein Sci., 2009, 18, 707-715.
28. Wei, D. Q.; Du, Q. S.; Sun, H.; Chou, K. C. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. Biochem. Biophys. Res. Comm., 2006, 344, 1048-1055.
29. Wang, S. Q.; Du, Q. S.; Chou, K. C. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases. Biochem. Biophys. Res. Comm., 2007, 354, 634-640.
30. Du, Q. S.; Wang, S. Q.; Chou, K. C. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem. Biophys. Res. Comm., 2007, 362, 525-531.
31. Gong, K.; Li, L.; Wang, J. F.; Cheng, F.; Wei, D. Q.; Chou, K. C. Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design. Med. Chem., 2009, 5, 242-249.
32. Du, Q. S.; Huang, R. B.; Wang, S. Q.; Chou, K. C. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus. PLoS One, 2010, 5, e9388.
33. Du, Q. S.; Huang, R. B.; Wang, C. H.; Li, X. M.; Chou, K. C. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J. Theor. Biol., 2009, 259, 159-164.
34. Wei, H.; Wang, C. H.; Du, Q. S.; Meng, J.; Chou, K. C. Investigation into adamantane-based M2 inhibitors with FB-QSAR. Med. Chem., 2009, 5, 305-317.
35. Wang, S. Q.; Cheng, X. C.; Dong, W. L.; Wang, R. L.; Chou, K. C. Three new powerful Oseltamivir derivatives for inhibiting the neuraminidase of influenza virus. Biochem. Biophys. Res. Commun., 2010, 401, 188-191.
36. Fedorov, D. G.; Kitaura, K. Eds.; The Fragment Molecular Orbital Method: Practical Applications to Large Molecular Systems; CRC Press: Boca Raton, FL, 2009.
37. Fedorov, D.G.; Kitaura, K. Extending the Power of Quantum Chemistry to Large Systems with the Fragment Molecular Orbital Method. J. Phys. Chem., 2007, A 111, 6904-6914. (Pubitemid 47321628)
38. Iwata, T.; Fukuzawa, K.; Nakajima, K.; Aida-Hyugaji, S.; Mochizuki, Y.; Watanabe, H.; Tanaka, S. Theoretical analysis of binding specificity of influenza viral hemagglutinin to avian and human receptors based on the fragment molecular orbital method Comp. Biol. Chem., 2008, 32, 198-211. (Pubitemid 351657771)
39. Sawada, T.; Hashimoto, T., Nakano, H.; Suzuki, T.; Ishida, H.; Kiso, M. Why does avian influenza A virus hemagglutinin bind to avian receptor stronger than to human receptor? Ab initio fragment molecular orbital studies. Biochem. Biophys. Res. Comm., 2006, 351, 40-43. (Pubitemid 44635403)
40. Sawada, T.; Hashimoto, T.; Tokiwa, H.; Suzuki, T.; Nakano, H.; Ishida, H.; Kiso, M.; Suzuki, Y. Ab initio fragment molecular orbital studies of influenza virus hemagglutinin-sialosaccharide complexes toward chemical clarification about the virus host range determination. Glycoconj. J., 2008, 25, 805-815.
41. Takematsu, K.; Fukuzawa, K.; Omagari, K.; Nakajima, S.; Nakajima, K.; Mochizuki, Y.; Nakano, T.; Watanabe, H.; Tanaka, S. Possibility of Mutation Prediction of Influenza Hemagglutinin by Combination of Hemadsorption Experiment and Ab Initio Calculation for Antibody Binding. J. Phys. Chem., 2009, B 113, 49914994.
42. Mochizuki, Y.; Yamashita, K.; Murase, T.; Nakano, T.; Fukuzawa, K.; Takematsu, K.; Watanabe, H.; Tanaka, S. Large scale FMOMP2 calculations on a massively parallel-vector computer. Chem. Phys. Lett., 2008, 457, 396-403.
43. Mochizuki, Y.; Yamashita, K.; Fukuzawa, K.; Takematsu, K.; Watanabe, H.; Taguchi, N.; Okiyama, Y.; Tsuboi, M.; Nakano, T.; Tanaka, S. Large-scale FMO-MP3 calculations on the surface proteins of influenza virus, hemagglutinin (HA) and neuraminidase (NA). Chem. Phys. Lett., 2010, 493, 346-352.
44. Fukuzawa, K.; Mochizuki, Y.; Tanaka, S.; Kitaura, K.; Nakano, T. Molecular Interactions between Estrogen Receptor and Its Ligand Studied by the Ab Initio Fragment Molecular Orbital Method. J. Phys. Chem. B, 2006, 110, 16102-16110. (Pubitemid 44375678)
45. Chou, K. C. Review: Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004. 11. 2105-2134.
46. Chou, K. C. Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. Biochem. Biophys. Res. Commun., 2004, 316, 636-642.
47. Chou, K. C. Molecular therapeutic target for type-2 diabetes. J. Proteome Res., 2004, 3, 1284-1288.
48. Ban, H. S.; Usui, T.; Nabeyama, W.; Morita, H.; Fukuzawa, K.; Nakamura, H. Discovery of Boron-conjugated 4-Anilinoquinazoline as a Prolonged Inhibitor of EGFR Tyrosine Kinase. Org. Biomol. Chem., 2009, 7, 4415-4427.
49. Chou, K. C.; Wei, D. Q.; Zhong, W. Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. (Erratum: ibid., 2003, Vol.310, 675). Biochem. Biophys. Res. Comm., 2003, 308, 148-151.
50. He, Z. S.; Zhang, J.; Shi, X. H.; Hu, L. L.; Kong, X. G.; Cai, Y. D.; Chou, K. C. Predicting drug-target interaction networks based on functional groups and biological features. PLoS One, 2010, 5, e9603.
51. Chou, K. C.; Wei, D. Q.; Du, Q. S.; Sirois, S.; Zhong, W. Z. Review: Progress in computational approach to drug development against SARS. Curr. Med. Chem., 2006, 13, 3263-3270. (Pubitemid 44669774)
52. Chou, K. C. Energy-optimized structure of antifreeze protein and its binding mechanism. J. Mol. Biol., 1992, 223, 509-517.
53. Chou, K. C.; Jones, D.; Heinrikson, R. L. Prediction of the tertiary structure and substrate binding site of caspase-8. FEBS Lett., 1997, 419, 49-54. (Pubitemid 28011215)
54. Chou, K. C. Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein. J Proteome Res., 2005, 4, 1681-1686.
55. Wang, J. F.; Wei, D. Q.; Li, L.; Zheng, S. Y.; Li, Y. X.; Chou, K. C. 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. Biochem. Biophys. Re.s Commun., (Corrigendum: ibid, 2007, Vol. 357, 330), 2007, 355, 513-519. (Pubitemid 46282658)
56. Li, L.; Wei, D. Q.; Wang, J. F.; Chou, K. C. Computational studies of the binding mechanism of calmodulin with chrysin. Biochem. Biophys. Res. Comm., 2007, 358, 1102-1107. (Pubitemid 46829002)
57. Wang, J. F.; Wei, D. Q.; Lin, Y.; Wang, Y. H.; Du, H. L.; Li, Y. X.; Chou, K. C. Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP. Biochem. Biophys. Res. Comm., 2007, 359, 323-329. (Pubitemid 46887686)
58. Gu, R. X.; Gu, H.; Xie, Z. Y.; Wang, J. F.; Arias, H. R.; Wei, D. Q.; Chou, K. C. Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor. Med. Chem., 2009, 5, 250-262.
59. Wang, J. F.; Yan, J. Y.; Wei, D. Q.; Chou, K. C. Binding of CYP2C9 with diverse drugs and its implications for metabolic mechanism. Med. Chem., 2009, 5, 263-270.
60. Wang, J. F.; Wei, D. Q.; Chen, C.; Li, Y.; Chou, K. C. Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design. Protein Pept. Lett., 2008, 15, 27-32. (Pubitemid 351206472)
61. Case, D. A.; Darden, T. A.; Cheatham, T. E.; Simmerling, III, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Walker, R. C.; Zhang, W.; Merz, K. M.; Roberts, B. P.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Kolossváry, I.; Wong, K. F.; Paesani, F.; Vanicek, J.; Wu, X.; Brozell, S. R.; Steinbrecher, T.; Gohlke, H.; Cai, Q.; Ye, X.; Wang, J.; Hsieh, M.-J.; Cui, G.; Roe, D. R.; Mathews, D. H.; Seetin, M. G.; Sagui, C.; Babin, V.; Luchko, T.; Gusarov, S.; Kovalenko, A.; Kollman, P. A. AMBER 11. University of California: San Francisco, 2010.
62. Nakano, T.; Kaminuma, T.; Sato, T.; Fukuzawa, K.; Akiyama, Y.; Uebayasi, M.; Kitaura, K. Frgment Molecular Orbital Method: Use of Approximate Electrostatic Potential. Chem. Phys. Lett., 2002, 351, 475-480.
63. Mochizuki, Y.; Nakano, T.; Koikegami, S.; Tanimori, S.; Abe, Y.; Nagashima, U.; Kitaura, K. A parallelized integral-direct secondorder Møller-Plesset perturbation theory method with a fragment molecular orbital scheme. Theor. Chem. Acc., 2004, 112, 442-452. (Pubitemid 40100848)
64. Mochizuki, Y.; Koikegami, S.; Nakano, T.; Amari, S.; Kitaura, K. Large scale MP2 calculations with fragment molecular orbital scheme. Chem. Phys. Lett., 2004, 396, 473-479.
65. Grimme, S. J. Improved second-order Møller-Plesset perturbation theory by separate scaling of parallel- and antiparallel-spin pair correlation energies. Chem. Phys., 2003, 118, 9095-9102.
66. Hill, J. G.; Platts, J. A. Spin-Component Scaling Methods for Weak and Stacking Interactions. Phys. Chem. Chem. Phys., 2006. 8. 4072-4078.
67. Sawada, T.; Fedorov, D. G.; Kitaura, K. Structural and Interaction Analysis of Helical Heparin Oligosaccharides with the Fragment Molecular Orbital Method. Int. J. Quantum Chem., 2009, 109, 2033-2045.
68. ABINIT-MP ver 4.3 and BioStation Viewer ver. 12.0 is available from the website of RSS21 project: http://www.ciss.iis.utokyo.ac.jp/dl.
69. CLUSTALW version 1.83: http://clustalw.ddbj.nig.ac.jp
70. Fukuzawa, K.; Mochizuki, Y.; Tanaka, S.; Kitaura, K.; Nakano, T. Molecular Interactions between Estrogen Receptor and Its Ligand Studied by the Ab Initio Fragment Molecular Orbital Method. ibid., 2006, 110, 24276-24276.